Showing results (331-340 of 346) with videos related to
Sort By:
Pageof 35
Epilepsy & Behavior : E&B|March 25, 2008
The Wada test in Austrian, Dutch, German, and Swiss epilepsy centers from 2000 to 2005: a review of 1421 proceduresA Haag, S Knake, H M Hamer, et al.Nature Immunology|August 16, 2011
Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiationMarc Beyer, Yasser Thabet, Roman-Ulrich Müller, et al.Blood|December 28, 2020
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trialSilke Kapp-Schwoerer, Daniela Weber, Andrea Corbacioglu, et al.Scientific Reports|December 29, 2019
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vectorM Giel-Moloney, M Esteban, B H Oakes, et al.Immunity|September 18, 2020
A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the LiverLawrence T Wang, Lais S Pereira, Yevel Flores-Garcia, et al.Clinical and Translational Science|February 18, 2014
Collaborative approach in the development of high-performance brain-computer interfaces for a neuroprosthetic arm: translation from animal models to human controlJennifer L Collinger, Michael A Kryger, Richard Barbara, et al.Nature Communications|December 14, 2023
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trialsDaniel B Reeves, Bryan T Mayer, Allan C deCamp, et al.Nature Medicine|May 13, 2022
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trialBoris Julg, Kathryn E Stephenson, Kshitij Wagh, et al.Cancer Discovery|April 21, 2026
Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II studySalah-Eddine Bentebibel, Daniel J McGrail, Veena Kochat, et al.Biorxiv : the Preprint Server for Biology|October 28, 2024
A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIVMohammad M Sajadi, Abdolrahim Abbasi, Zahra Rikhtegaran Tehrani, et al.Pageof 35